|
AU2017231891A1
|
|
Phospholipid preparations for the improvement of brain plasticity
|
|
WO2017153998A1
|
|
Lipid compositions and uses thereof
|
|
WO2017125816A1
|
|
Methods using phosphatidylserine powder
|
|
US2019327997A1
|
|
Oil blends and processes for their preparation
|
|
WO2017009711A1
|
|
Phospholipid preparations for the improvement of sleep
|
|
US2018139998A1
|
|
Lipid compositions for improving sleep
|
|
KR20170095246A
|
|
Phospholipid preparations for improving communication skills
|
|
WO2016055860A1
|
|
Marine lecithin preparations with enhanced oxidation resistance
|
|
US2017209471A1
|
|
Nutritional compositions containing phosphatidylserine powder
|
|
CN107529805A
|
|
Composition comprising choline and its derivative, preparation method and use
|
|
IL237290D0
|
|
Oil blends for use in formulas
|
|
CA2932766A1
|
|
Serine glycerophospholipid preparation and method for treatment of seizures
|
|
EP3060202A1
|
|
Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation
|
|
CN102843921A
|
|
Methods and lipid compositions for promoting development of gut flora
|
|
IL210199D0
|
|
Glycerophospholipids for the improvement of cognitive functions
|
|
IL204926D0
|
|
Lipid compositions for the tratment of gastro- intestinal disorders and the promotion of intestinal development and maturation
|
|
CN101909467A
|
|
Lipid mixture for infant nutrition
|
|
US2009131523A1
|
|
Lipid compositions for the treatment and prevention of proliferative diseases and for the reduction of incidences of mutagenesis and carinogenesis
|
|
BRPI0818079A2
|
|
lipid composition
|
|
US2009074857A1
|
|
Glycerophospholipids for the improvement of cognitive functions
|
